| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065140 Antidepressant; side effect reduction |
| 03/24/2005 | US20050065123 Administering to a post menopausal woman an effective amount of 2-methylene -19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 |
| 03/24/2005 | US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents |
| 03/24/2005 | US20050065108 Antidiabetic agents; antilipemic agents |
| 03/24/2005 | US20050065102 Medicinal compositions |
| 03/24/2005 | US20050065098 Antidiabetic agents; hypoglycemic agents; dietetics; bioavailability |
| 03/24/2005 | US20050065095 Antibacterial agents |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050065069 Use of hcg in controlled ovarian hyperstimulation |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064539 Glycoprotein and process for producing the same |
| 03/24/2005 | US20050064534 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064522 EG-VEGF nucleic acids and polypeptides and methods of use |
| 03/24/2005 | US20050064493 Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor |
| 03/24/2005 | US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064453 Kit which utilizes interleukin-1-related gene as diagnostic/prognostic tool in detection of urogenital disorders; genomics and bioinformatics |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064413 Oncogenic protein for use in diagnosis, prevention and treatment of cell proliferative disorders of nervous ystem |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064018 Use of vitamin D compounds |
| 03/24/2005 | US20050063991 administrating. to a diabetic or arteriosclerosis patient an effective amount of crude Dunaliella powder containing an approximately 1:1 ratio of all-trans and 9-cis beta -carotene |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063965 Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes |
| 03/24/2005 | US20050063943 Conjugated of hydroxyalkyl starch and an active agent |
| 03/24/2005 | US20050063905 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); polycythemia vera, macroglobulinemia (Waldenstrom syndrome), megakaryocytic myelosis, malignant histiocytosis |
| 03/24/2005 | US20050063902 Stabiliser for radiopharmaceuticals |
| 03/24/2005 | DE102004039012A1 Pipermethystine-free extract of Piper methysticum useful for treating anxiety, nervous tension and agitation |
| 03/24/2005 | CA2537841A1 Modulators of atp-binding cassette transporters |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516878A1 Refreshment capable of stimulating movement of digestive tract |
| 03/23/2005 | EP1516872A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 03/23/2005 | EP1516871A1 Benzoindoline derivatives with adrenergic activity |
| 03/23/2005 | EP1516621A2 Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases |
| 03/23/2005 | EP1516620A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 03/23/2005 | EP1516617A2 Use of a thiazolidinedione for reducing apoptosis of pancreatic beta cells |
| 03/23/2005 | EP1516540A1 Use of vitamin D compounds |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1516047A1 Purified pkb ser 473 kinase and uses thereof |
| 03/23/2005 | EP1516044A2 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 03/23/2005 | EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/23/2005 | EP1515972A1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 03/23/2005 | EP1515971A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 03/23/2005 | EP1515968A2 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 03/23/2005 | EP1515961A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 03/23/2005 | EP1515960A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 03/23/2005 | EP1515959A1 Pharmaceutical salts of reboxetine |
| 03/23/2005 | EP1515949A1 Mitotic kinesin inhibitors |
| 03/23/2005 | EP1515941A1 2-naphthamide derivatives |
| 03/23/2005 | EP1515926A2 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 03/23/2005 | EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 03/23/2005 | EP1515750A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 03/23/2005 | EP1515745A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 03/23/2005 | EP1515744A2 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
| 03/23/2005 | EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 03/23/2005 | EP1515736A1 Compositions against inflammatory processes |
| 03/23/2005 | EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 03/23/2005 | EP1515725A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 03/23/2005 | EP1515724A1 Mitotic kinesin inhibitors |
| 03/23/2005 | EP1515721A1 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515720A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions |
| 03/23/2005 | EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 03/23/2005 | EP1515718A2 Modulation of activation of glucocorticoid receptors by breakdown products of glucocorticoids |
| 03/23/2005 | EP1515709A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 03/23/2005 | EP1515708A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 03/23/2005 | EP1515707A2 Method of treating atherosclerosis and other inflammatory diseases |
| 03/23/2005 | EP1515704A1 Microcapsules for the delayed, controlled release of perindopril |
| 03/23/2005 | EP1421182A4 Methods of inducing differentiation of stem cells |
| 03/23/2005 | EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 03/23/2005 | EP1345618B1 Chlorzoxazone for the treatment of psoriasis |
| 03/23/2005 | EP1328268B1 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 03/23/2005 | EP1297119B9 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current |
| 03/23/2005 | EP1280528B1 R-eliprodil for treating glaucoma |
| 03/23/2005 | EP1272218B1 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
| 03/23/2005 | EP1098647B1 Compounds and compositions for treating tissue ischemia |
| 03/23/2005 | EP1089733B1 Use of optically pure (+)-norcisapride for treating irritable bowel syndrome |
| 03/23/2005 | EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 03/23/2005 | CN1599753A Gene regulatory peptides |
| 03/23/2005 | CN1599750A Cytotoxic protein and utilization thereof |
| 03/23/2005 | CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 03/23/2005 | CN1599741A Thioether substituted imidazoquinolines |
| 03/23/2005 | CN1599740A Amide substituted imidazopyridines |
| 03/23/2005 | CN1599739A Sulfonamido substituted imidazopyridines |
| 03/23/2005 | CN1599738A Urea substituted imidazopyridines |
| 03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
| 03/23/2005 | CN1599736A Process for the preparation of 4-(8-chloro-5, 6-dihydro-11h-benzo(5, 6)-cyclohepta-(1, 2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
| 03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
| 03/23/2005 | CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor |
| 03/23/2005 | CN1599731A Benzothiazepine derivatives |
| 03/23/2005 | CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/23/2005 | CN1599728A 1, 2, 4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 03/23/2005 | CN1599725A Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control |
| 03/23/2005 | CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/23/2005 | CN1599721A CCR-3 receptor antagonists VII |
| 03/23/2005 | CN1599720A Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr) |